These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 18929781

  • 1. Experience of the transplant team is an important factor for posttransplant survival in patients with hepatocellular carcinoma undergoing living-donor liver transplantation.
    Majeed TA, Wai CT, Rajekar H, Lee KH, Wong SY, Leong SO, Singh R, Tay KH, Chen J, Tan KC.
    Transplant Proc; 2008 Oct; 40(8):2507-9. PubMed ID: 18929781
    [Abstract] [Full Text] [Related]

  • 2. Living-donor liver transplantation for hepatocellular carcinoma.
    Kaihara S, Kiuchi T, Ueda M, Oike F, Fujimoto Y, Ogawa K, Kozaki K, Tanaka K.
    Transplantation; 2003 Feb 15; 75(3 Suppl):S37-40. PubMed ID: 12589138
    [Abstract] [Full Text] [Related]

  • 3. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.
    Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, Shimada M, Maehara Y.
    Transplantation; 2007 Apr 15; 83(7):893-9. PubMed ID: 17460559
    [Abstract] [Full Text] [Related]

  • 4. The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma.
    Yokoi H, Isaji S, Yamagiwa K, Tabata M, Nemoto A, Sakurai H, Usui M, Uemoto S.
    J Hepatobiliary Pancreat Surg; 2006 Apr 15; 13(2):123-30. PubMed ID: 16547673
    [Abstract] [Full Text] [Related]

  • 5. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
    Hwang S, Lee SG, Joh JW, Suh KS, Kim DG.
    Liver Transpl; 2005 Oct 15; 11(10):1265-72. PubMed ID: 16184545
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: the controversies continue.
    Lee HS.
    Dig Dis; 2007 Oct 15; 25(4):296-8. PubMed ID: 17960062
    [Abstract] [Full Text] [Related]

  • 12. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria.
    Fouzas I, Sotiropoulos GC, Lang H, Nadalin S, Beckebaum S, Sgourakis G, Saner FH, Radtke A, Papanikolaou V, Baba HA, Paul A, Broelsch CE, Malagó M.
    Transplant Proc; 2008 Nov 15; 40(9):3185-8. PubMed ID: 19010228
    [Abstract] [Full Text] [Related]

  • 13. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J.
    Br J Surg; 2007 Jan 15; 94(1):78-86. PubMed ID: 17016793
    [Abstract] [Full Text] [Related]

  • 14. Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria.
    Woo HY, Jang JW, Choi JY, You CR, Jeong SW, Bae SH, Yoon SK, Lee YS, Kim DG.
    Liver Int; 2008 Sep 15; 28(8):1120-8. PubMed ID: 18492023
    [Abstract] [Full Text] [Related]

  • 15. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.
    Transplant Proc; 2012 Mar 15; 44(2):516-9. PubMed ID: 22410059
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report.
    Malagó M, Sotiropoulos GC, Nadalin S, Valentin-Gamazo C, Paul A, Lang H, Radtke A, Saner F, Molmenti E, Beckebaum S, Gerken G, Frilling A, Broelsch CE.
    Liver Transpl; 2006 Jun 15; 12(6):934-40. PubMed ID: 16528715
    [Abstract] [Full Text] [Related]

  • 18. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, Harada N, Yamashita Y, Sugimachi K, Kayashima H, Iguchi T, Maehara Y.
    Transplantation; 2009 Feb 27; 87(4):531-7. PubMed ID: 19307789
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW, Yi NJ, Suh KS.
    Transplantation; 2014 Apr 27; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.